Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

Prescriber Guidelines for Risk Mitigation in the Context of Dual Public Health Emergencies: Notification to All Prescribers in the Vancouver Coastal Health (VCH) Region

Prescriber Guidelines for risk mitigation in BC from Vancouver Coastal Health
Guidelines | 2020
Clinical guidance, Harm reduction, Policy/Regulatory, Safer supply, About prescribers, Stimulants, Substitution/OAT, Injecting drugs

Education and equipment for people who smoke crack cocaine in Canada: progress and limits

Public health programming designed for this population is limited, particularly in comparison with programming for people who inject drugs.
Original research | 2017
Harm reduction, Illegal drugs, Stimulants

The cocaine-e-cigarette – A theoretical concept of a harm reduction device for current users of smokable cocaine forms

This manuscript describes basic functionality and general specifications of a cocaine-e-cigarette as a medical device treating people with respective cocaine use disorder when cessation and substituti
Original research | 2021
Harm reduction, Safer supply, Illegal drugs, Stimulants, Stigma

2019 Opioid Mortality in Ontario and preliminary 2020 trends

Slide deck | 2020
Mortality, Evidence base, Advocacy, Illegal drugs, Indigenous, Stimulants, Sex/Gender

Possible benefits of providing safe supply of substances to people who use drugs during public health emergencies such as the COVID-19 pandemic

To describe the possible benefits of offering safe supply to people who use drugs during public health emergencies like COVID-19
Commentary | 2020
Safer supply, Stimulants

Changing Circumstances Surrounding Opioid-Related Deaths in Ontario during the COVID-19 Pandemic

Infographic | 2021
Overdose, Mortality, Evidence base, Advocacy, Housing, Illegal drugs, Workplace, Rural/remote, Stimulants, Sex/Gender

Changing Circumstances Surrounding Opioid-Related Deaths in Ontario during the COVID-19 Pandemic

Update data from the 2020 preliminary report on opioid-related deaths before and during the pandemic
Report | 2021
Overdose, Mortality, Evidence base, Advocacy, Housing, Illegal drugs, Workplace, Rural/remote, Stimulants, Sex/Gender

Substance Replacement Therapy in the Context of the COVID-19 Pandemic in Québec: Clinical Guidance for Prescribers

Quebec safe supply clinical guidance for prescribers
Guidelines | 2020
Overdose, Clinical guidance, Harm reduction, Safer supply, About prescribers, Stimulants, Substitution/OAT, Transitions in care/treatment, Injecting drugs

The drug toxicity and overdose crisis in Canada: a snapshot of what the current data tell us

This article provides a snapshot of data released by Health Canada on opioid- and stimulant-related harms and data from two provinces detailing a concerning trend in the nature of drug toxicity dea

Newsletter | 2021
Overdose, Mortality, Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Illegal drugs, Stimulants, SCS/OPS

Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market

This qualitative study was conducted to better understand how people who inject drugs (PWID) came to recognize fentanyl as a growing adulterant of heroin and the subsequent sensory discernment strateg
Original research | 2022
Harm reduction, About PWUD, Illegal drugs, Stimulants

Stimulant safe supply: a potential opportunity to respond to the overdose epidemic

Commentary | 2020
Safer supply, Equity, Barriers and enablers, Poverty, Stimulants, Peer/PWLLE program involvement

National Injectable Opioid Agonist Treatment Guideline

The clinical guideline was developed to provide key clinical recommendations, as well as clinical guidance on the provision of iOAT.
Guidelines | 2019
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Illegal drugs, Stimulants, Transitions in care/treatment, Injecting drugs

Safe Supply Concept Document

To outline the concept of safe supply including its role in drug policy
Commentary | 2019
Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Equity, Advocacy, About PWUD, Stimulants

What prescribers should know about COVID-19, Substance Use and Safe Supply: New provincial clinical guidance April 2020

Slide deck | 2020
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Stimulants, Substitution/OAT, Transitions in care/treatment

Refine Your Search

Keywords
Format
Region